360° Coverage : If You Don't Market Drugs, How Do You Expect To Sell Them?

2 Updates

If You Don't Market Drugs, How Do You Expect To Sell Them?

Jan 2 2014, 8:39am CST | by

The sales and marketing of new medicines provide a lightning rod for discussions about all that is wrong with the biopharmaceutical industry. Certainly, there have been over-aggressive practices...

Filed under: news

 
 
 

42 weeks ago

If You Don't Market Drugs, How Do You Expect To Sell Them?

Jan 2 2014, 8:39am CST | by

The sales and marketing of new medicines provide a lightning rod for discussions about all that is wrong with the biopharmaceutical industry. Certainly, there have been over-aggressive practices used by the industry in terms of free dinners and paid conferences, but these practices are becoming less utilized. However, sales reps need to interact with doctors to prescribe their drugs. After all, this is their life blood.

GSK has recently announced that it is changing the way that sales reps will be compensated. Instead of tying compensation to the number of prescriptions written by doctors with whom they interact, the reps will be paid based on their technical knowledge, the quality of service they provide to clients, and the company’s business performance. The GSK changes have inspired a lot of comments, many applauding GSK for this and speculating on whether other companies will follow suit.

However, there are some comments that totally exasperate me. The most egregious to me was the post on Forbes.com by psychiatrist, Dr. Dale Archer, entitled “The Dark Side Of Big Pharma”. Archer feels that the entire practice of compensating sales reps based on prescriptions written is: “a practice rife with conflict of interest, leading to over-prescription of medications that may not even be the most appropriate for patients…” He goes on to say that: “When you incentivize a sales person with a hefty bonus check based on the number of prescriptions emanating from their territory, they’ll find a way to get doctors to write their drug.”

Archer describes why this is a problem. “This is key, because, no matter how principled we believe we are as doctors, we are only human, and the dark side of Big Pharma casts a long shadow. There can be no doubt when a charming drug rep visits your practice and introduces you to the latest product, it’s going to be at the top of your mind the next time you pull out your Rx pad.”

Is this really the case? Do sales reps so entrance a psychiatrist that he/she can’t wait to start writing prescriptions? If this is the case, why do physicians even agree to see sales reps in the first place? Actually, Archer answers that himself: “And to be fair, pharmaceutical reps do serve a need by bringing new information to doctors that may be too busy to keep up.” So, he admits that sales reps do bring value. When Archer was practicing psychiatry full time, he was undoubtedly seeing various sales reps who were touting the benefits of various antidepressants, such as Paxil (GSK), Prozac (Lilly) and Zoloft (Pfizer). He was also getting information from sales reps on antipsychotic medications like Geodon (Pfizer) and Abilify (BMS). I find it hard to believe that he changed his prescribing practice each time a sales rep left his office and that a new antidepressant or antipsychotic was now “at the top of his mind”. My guess is that he tried a variety of medicines, found what worked best for his patients and stayed with that particular drug as is the habit of most doctors. But the information from each sales rep helped to shape his views. Why is this bad?

Certainly, sales reps will highlight the benefits of the drug that they are selling. They will also talk about why their drug is better than competitive agents. As a result, when a doctor hears about a number of drugs, he/she can get a feel of the strengths and weaknesses of each drug and then treat patients accordingly. That’s not a bad system. However, at the end, it all comes down to the doctor’s judgment. Articles like Archer’s make it seem that doctors are mindless and prescribe new medicines whimsically. I think that this does all doctors a disservice. If a doctor prescribes a drug based on how “charming” a sales rep is, we have a major problem.

While some might find it unfortunate, the reality is that, for medicines to reach patients, they must be sold through sales and marketing. Without this, new drugs will never recoup the enormous investment needed to support the biopharmaceutical industry. A doctor can get information from a variety of sources – medical journals, scientific meetings AND sales reps. But the latter are a key component of getting new drugs to patients and, unless a better system can be devised, this practice will continue.

Source: Forbes Business

 
Update
2

8 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new compa ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

8 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Slovakia to provide further financial help in fighting Ebola
Bratislava, Oct 26 (IANS) Slovakia planned to provide some 90,000 euros ($114,000) to countries affected by Ebola to help with the construction of field hospitals, foreign ministry said Saturday.
 
 
Mauritania closes border with Mali after Ebola death
Nouakchott, Oct 26 (IANS) Mauritania has closed its border with Mali after an Ebola death was confirmed in the border area this week, a health official said Saturday.
 
 
Number of Ebola cases crosses 10,000: WHO
Geneva, Oct 25 (IANS/EFE) The World Health Organisation (WHO) confirmed Saturday that the number of Ebola cases has risen to more than 10,000 in the eight affected countries, two of which, Nigeria and Senegal, had recently been declared free of the virus.
 
 
India-born Sundar Pichai is Google's new product chief
Washington, Oct 25 (IANS) In a major restructuring of Google management, India-born Sundar Pichai, who is already in-charge of Android, Chrome and Google Apps, has been made the chief of core Google products, according to a technology magazine.
 
 
 

Latest from the Network

Second MERS case reported in Qatar
Doha, Oct 23 (IANS) A 43-year-old man in Qatar has tested positive for Middle East Respiratory Syndrome (MERS) in the second confirmed case of the deadly virus in 10 days, media reported Thursday. The patient had...
Read more on Business Balla
 
Two people die in Pakistan bomb blast
Islamabad, Oct 23 (IANS) At least two people were killed and 12 others injured in an explosion that took place in Pakistan's Balochistan province Thursday, media reported. The bomb was planted on a motorcycle, Dawn...
Read more on Politics Balla
 
Trott extends contract with Warwickshire till 2017
London, Oct 23 (IANS) England batsman Jonathan Trott, whose mental issues led to his abrupt departure from last winter's Ashes tour, has confirmed his successful comeback to competitive cricket by signing a new three-...
Read more on Sport Balla
 
Srikanth, Kashyap big movers in BWF rankings
Kuala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest Badminton World Federation (BWF) rankings released Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Alvin Stardust dead
London, Oct 23 (IANS) English singer Alvin Stardust died after a short illness. He was 72. Stardust's manager confirmed the news about his demise Thursday, reports mirror.co.uk. He was recently diagnosed with...
Read more on Celebrity Balla
 
Indian man reunited with family after 40 years
Dubai, Oct 23 (IANS) An Indian man, who had disappeared from his hometown in Kerala nearly 40 years ago, has been found by his family at a hospital in Dubai in the UAE, a newspaper report said. Now in his 60s, Abdulla...
Read more on Politics Balla
 
Srikanth, Kashyap, Saina rise in world rankings
Kala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest released Badminton World Federation (BWF) rankings Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Flintoff signs for Big Bash side Brisbane Heat
Brisbane, Oct 23 (IANS) Former England captain and all-rounder Andrew Flintoff, who retired from international cricket in 2009, Wednesday confirmed that he will play for Brisbane Heat in the Big Bash League (BBL) this...
Read more on Sport Balla
 
OPEC daily basket price falls again
Vienna, Oct 23 (IANS/WAM) The basket of 12 crude oils of the Organization of Petroleum Exporting Countries (OPEC) closed at $81.94 a barrel Wednesday compared to $82.09 Tuesday, the OPEC Secretariat said. The new OPEC...
Read more on Business Balla
 
Lopez to sign multi-million dollar deal?
Los Angeles, Oct 23 (IANS) Singer-actress Jennifer Lopez is reportedly in the final stages of securing a multi-million dollar deal to perform in Las Vegas. The 45-year-old is being offered $350,000 per show at The...
Read more on Celebrity Balla